Heart Replicas Enhance Success Rates for Cardiac Ablation

Researchers at Johns Hopkins University have achieved a 100% success rate in treating ventricular tachycardia using personalized digital heart twins. The results of the FDA-approved TWIN-VT clinical trial were published in the New England Journal of Medicine on April 2, 2026.

The study demonstrated that using digital replicas of a patient’s heart to guide ablation procedures is significantly more effective than traditional methods. While traditional ablation treatment typically has a long-term success rate of 60%, the digital twin approach eliminated arrhythmias in all 10 patients involved in the trial.

Personalized Modeling and Procedure Planning

To implement this approach, the research team created personalized 3D digital models of each participant’s heart based on MRI scans. These digital twins allowed doctors to identify the precise areas of the heart that were sparking the arrhythmias.

Once the models were established, physicians tested and planned the optimal ablation procedure on the digital replicas before performing the actual operation on the patient. This process resulted in procedures that were faster and more accurate than standard methods.

By using these predictions to streamline the ablation, doctors were able to target the faulty heart rhythms with greater precision, reducing the likelihood of recurrence.

Patient Outcomes and Long-Term Success

The clinical trial tracked 10 patients to evaluate the safety and feasibility of the digital twin method. Following the guided ablations, all 10 participants remained free of arrhythmias for more than one year.

Beyond the elimination of the arrhythmias, the treatment had a significant impact on medication dependency. Eight of the 10 patients were able to stop taking anti-arrhythmia medications entirely after the procedure.

Impact on Personalized Medicine

This development is described as a breakthrough in personalized medicine, as it provides a way for doctors to diagnose, treat and predict outcomes for patients with life-threatening heart rhythm disorders with a level of precision previously unavailable.

Ventricular tachycardia is often difficult to treat effectively using traditional ablation techniques. The ability to simulate a procedure on a digital replica before treating the physical heart could transform the standard of care for this and similar conditions.

The TWIN-VT trial suggests that integrating personalized cardiac modeling into clinical practice can reduce the risks associated with traditional ablation and improve the long-term prognosis for patients suffering from severe heart rhythm disorders.